Vimarsana
Biggest News Aggregation in the World

Michael Gantier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Gantier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Gantier Today - Breaking & Trending Today

Noxopharm SOF-VAC asset 'markedly' reduces mRNA vaccine-related inflammation, study shows - Vimarsana News

Noxopharm SOF-VAC asset 'markedly' reduces mRNA vaccine-related inflammation, study shows

Noxopharm Ltd (ASX:NOX, OTC:NOXOF) has soared on fielding new data illustrating that its mRNA vaccine enhancer, SOF-VAC™, markedly reduces mRNA-induced...

Noxopharm soars as study shows SOF-VAC asset 'markedly' reduces mRNA vaccine-related inflammation - Vimarsana News

Noxopharm soars as study shows SOF-VAC asset 'markedly' reduces mRNA vaccine-related inflammation

Noxopharm Ltd (ASX:NOX, OTC:NOXOF) has soared on fielding new data illustrating that its mRNA vaccine enhancer, SOF-VAC™, markedly reduces mRNA-induced...

FIVE at FIVE AU: ASX extends the week's gains to 3%; Healthcare falls - Vimarsana News

FIVE at FIVE AU: ASX extends the week's gains to 3%; Healthcare falls

The ASX 200 has closed higher for its sixth consecutive day, bringing the index’s gain for the week to 3.1%.  The gains followed that of US markets...

Noxopharm talks partnership with Hudson Institute of Medical Research - Vimarsana News

Noxopharm talks partnership with Hudson Institute of Medical Research

Noxopharm Ltd (ASX:NOX, OTC:NOXOF) chief executive officer Dr Gisela Mautner joins Proactive alongside Associate Professor Michael Gantier from the Hudson...

Noxopharm and Hudson Institute collaborate on pioneering mRNA research - Vimarsana News

Noxopharm and Hudson Institute collaborate on pioneering mRNA research

In a recent interview, Noxopharm Ltd (ASX:NOX, OTC:NOXOF)’s CEO Dr Gisela Mautner joins Proactive alongside Associate Professor Michael Gantier from the...